Philips Respironics, Inc. recalls Philips Respironics — Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators

Recall date

October 7, 2024

Source

U.S. Food & Drug Administration (FDA) — recall announcement

Brand / firm

Philips Respironics, Inc., Philips Respironics

Why it was recalled

The use of in-line nebulizers placed in certain locations may lead to aerosol deposits forming over time on the ventilator flow sensor. Should this occur, there is a possibility of inaccurate flow measurements affecting therapy. — Defect

What was recalled

Trilogy Evo, Trilogy Evo O2, Trilogy Evo Universal, and Trilogy EV300 ventilators